Scholarlink

<p>Curcumin and resveratrol are phytochemicals that require comprehensive investigation beyond their established anticancer properties to delineate their broader biological roles. Focusing on emerging radiobiological identification of natural radio-modulators from phytochemicals, especially polyphenols, to enhance the therapeutic efficacy of radiotherapy. Network pharmacology analysis was employed to identify bioactive compounds of curcumin and resveratrol and to elucidate their associated molecular targets and signalling pathways in breast cancer. The molecular docking analysis highlighted AKT (PDB ID: 2UZR), TNF (PDB ID: 4RSU), TP53 (PDB ID: 6VIP) as protein targets exhibiting comparatively favourable docking interaction profiles. In vitro radiation sensitivity experiments using low-dose X-rays were conducted to assess potential approaches for enhancing breast cancer radiotherapy. The primary aim of this study was to explore the potential targets of curcumin and resveratrol in breast cancer using network pharmacology and molecular docking, complemented by experimental evaluation as a preliminary screening of their radiation-modulating properties.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative evaluation of curcumin and resveratrol in breast cancer: network pharmacology, molecular docking, and in-vitro radio-modulating validation in MDA-MB-231 cells

  • 期刊论文

  • 发表日期：

    2026年7月3日

查看全文
  • Nishasri Sukumaran,
  • Sureka Chandrasekaran Senbagavadivoo,
  • Alagupandi Raman,
  • Priyadharshini Tamizhmani,
  • Gurusaravanan Packiaraj,
  • Thirunavukkarasu Velusamy

摘要

Curcumin and resveratrol are phytochemicals that require comprehensive investigation beyond their established anticancer properties to delineate their broader biological roles. Focusing on emerging radiobiological identification of natural radio-modulators from phytochemicals, especially polyphenols, to enhance the therapeutic efficacy of radiotherapy. Network pharmacology analysis was employed to identify bioactive compounds of curcumin and resveratrol and to elucidate their associated molecular targets and signalling pathways in breast cancer. The molecular docking analysis highlighted AKT (PDB ID: 2UZR), TNF (PDB ID: 4RSU), TP53 (PDB ID: 6VIP) as protein targets exhibiting comparatively favourable docking interaction profiles. In vitro radiation sensitivity experiments using low-dose X-rays were conducted to assess potential approaches for enhancing breast cancer radiotherapy. The primary aim of this study was to explore the potential targets of curcumin and resveratrol in breast cancer using network pharmacology and molecular docking, complemented by experimental evaluation as a preliminary screening of their radiation-modulating properties.